IRIS UniCatt

Giannarelli, Diana
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 2.149
NA - Nord America 1.808
EU - Europa 1.315
SA - Sud America 549
AF - Africa 57
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 2
Totale 5.890
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.694
SG - Singapore 784
IT - Italia 592
CN - Cina 472
BR - Brasile 450
VN - Vietnam 356
DE - Germania 149
FR - Francia 130
IN - India 92
HK - Hong Kong 86
BD - Bangladesh 85
FI - Finlandia 85
GB - Regno Unito 76
JP - Giappone 76
SE - Svezia 53
CA - Canada 52
AR - Argentina 45
ES - Italia 39
ID - Indonesia 39
IE - Irlanda 39
KR - Corea 39
MX - Messico 39
NL - Olanda 39
RU - Federazione Russa 26
IQ - Iraq 22
EC - Ecuador 21
ZA - Sudafrica 20
AT - Austria 18
PL - Polonia 18
TR - Turchia 17
CO - Colombia 11
UZ - Uzbekistan 11
PH - Filippine 10
PK - Pakistan 10
MA - Marocco 9
BE - Belgio 8
SA - Arabia Saudita 7
UA - Ucraina 7
CZ - Repubblica Ceca 6
IL - Israele 6
KG - Kirghizistan 6
TN - Tunisia 6
VE - Venezuela 6
AU - Australia 5
CL - Cile 5
DO - Repubblica Dominicana 5
LT - Lituania 5
AZ - Azerbaigian 4
CR - Costa Rica 4
DZ - Algeria 4
EG - Egitto 4
ET - Etiopia 4
JM - Giamaica 4
LB - Libano 4
NZ - Nuova Zelanda 4
PE - Perù 4
RO - Romania 4
AE - Emirati Arabi Uniti 3
AL - Albania 3
BG - Bulgaria 3
HN - Honduras 3
JO - Giordania 3
KE - Kenya 3
KZ - Kazakistan 3
TT - Trinidad e Tobago 3
UY - Uruguay 3
AO - Angola 2
BH - Bahrain 2
BO - Bolivia 2
CG - Congo 2
CH - Svizzera 2
DK - Danimarca 2
HU - Ungheria 2
IR - Iran 2
OM - Oman 2
PT - Portogallo 2
PY - Paraguay 2
RS - Serbia 2
XK - ???statistics.table.value.countryCode.XK??? 2
BN - Brunei Darussalam 1
BY - Bielorussia 1
CY - Cipro 1
DM - Dominica 1
EE - Estonia 1
GA - Gabon 1
GR - Grecia 1
GT - Guatemala 1
KW - Kuwait 1
LK - Sri Lanka 1
ML - Mali 1
MN - Mongolia 1
MY - Malesia 1
NI - Nicaragua 1
NO - Norvegia 1
PA - Panama 1
PS - Palestinian Territory 1
SI - Slovenia 1
SN - Senegal 1
TH - Thailandia 1
TO - Tonga 1
Totale 5.890
Salva come PNG Salva come JPEG
Città #
Singapore 434
San Jose 297
Ashburn 260
Rome 244
Hefei 123
Ho Chi Minh City 123
Hanoi 92
Beijing 91
Los Angeles 83
Milan 80
New York 80
Hong Kong 75
Tokyo 74
Lauterbourg 51
St Louis 51
Frankfurt am Main 49
Hyderabad 49
Helsinki 47
Munich 47
São Paulo 44
Dallas 39
The Dalles 39
Dublin 38
Seoul 38
Council Bluffs 34
Kent 32
Jakarta 26
Boardman 25
Buffalo 24
Da Nang 24
Orem 24
Lappeenranta 20
Santa Clara 20
Chicago 19
Nuremberg 18
Phoenix 18
Turku 18
Haiphong 17
Atlanta 16
Denver 16
Mexico City 16
Stockholm 16
Toronto 16
London 14
Montreal 14
Rio de Janeiro 14
Brooklyn 13
Castelvetrano 13
Düsseldorf 13
Guayaquil 13
Brasília 12
Poplar 12
Porto Alegre 12
Warsaw 12
Ankara 11
Bexley 11
Johannesburg 11
Moscow 11
Tashkent 11
Vienna 11
Florence 10
North Bergen 10
Paris 10
Shanghai 10
Turin 10
Amsterdam 9
Bari 9
Chennai 9
Maceió 9
Mumbai 9
Belo Horizonte 8
Boston 8
Campinas 8
Baghdad 7
Biên Hòa 7
Brussels 7
Bến Tre 7
Hải Dương 7
Madrid 7
Newark 7
San Francisco 7
Bishkek 6
Buenos Aires 6
Cattolica 6
City of London 6
Dhaka 6
Fortaleza 6
Houston 6
Manchester 6
Naples 6
Vancouver 6
Washington 6
Bologna 5
Charlotte 5
Kingston 5
Memphis 5
Nha Trang 5
Olomouc 5
Padua 5
Salvador 5
Totale 3.436
Salva come PNG Salva come JPEG
Nome #
The likelihood of being helped or harmed as a patient-centred tool to assess cyclin dependent kinase 4/6 inhibitors clinical impact and safety in metastatic breast cancer: a systematic review and sensitivity-analysis 178
Usefulness of differential time to positivity between catheter and peripheral blood cultures for diagnosing catheter-related bloodstream infection: Data analysis from routine clinical practice in the intensive care unit 157
Prospective Study Investigating the Efficacy and Safety of a Scalp Cooling Device for the Prevention of Alopecia in Women Undergoing (Neo)Adjuvant Chemotherapy for Breast Cancer 152
Epithelial ovarian cancer and brain metastases: might the BRCA status, PARP inhibitor administration, and surgical treatment impact the survival? 144
MOREOVER: multiomics MR-guided radiotherapy optimization in locally advanced rectal cancer 144
Impact of Comprehensive Genome Profiling on the Management of Advanced Non–Small Cell Lung Cancer: Preliminary Results From the Lung Cancer Cohort of the FPG500 Program 143
Back to the future: The impact of oestrogen receptor profile in the era of molecular endometrial cancer classification 143
An Innovative Scoring System to Select the Optimal Surgery in Breast Cancer after Neoadjuvant Chemotherapy 142
Accessible model predicts response in hormone receptor positive HER2 negative breast cancer receiving neoadjuvant chemotherapy 141
Benefit from maintenance with PARP inhibitor in newly diagnosed ovarian cancer according to BRCA1/2 mutation type and site: a multicenter real-world study 137
Validation of Esaso Classification of Diabetic Maculopathy 134
Conservative Surgery in cT4 Breast Cancer: Single-Center Experience in the Neoadjuvant Setting 130
Quality of life in patients with advanced ovarian cancer after primary debulking surgery versus neoadjuvant chemotherapy: Results from the randomised SCORPION trial (NCT01461850) 129
Radiomics analysis of ultrasound images to discriminate between benign and malignant adnexal masses with solid morphology on ultrasound 129
Sentinel-node biopsy in apparent early stage ovarian cancer: final results of a prospective multicentre study (SELLY) 127
Real-world outcomes of Adjuvant De Gramont versus Xelox chemotherapy in reSected gasTric cancER: a propensity score-matched analysis (ASTER study) 125
Role of radiomics in predicting early disease recurrence in locally advanced breast cancer patients: integration of radiomic features and RECIST criteria 124
Comparative Analysis of Comprehensive Genomic Profile in Thymomas and Recurrent Thymomas Reveals Potentially Actionable Mutations for Target Therapies 121
Integrating clinical-molecular data to predict PARP inhibitors efficacy in advanced ovarian cancer patients after interval cytoreductive surgery 118
Long-Term Safety of Level II Oncoplastic Surgery after Neoadjuvant Treatment for Locally Advanced Breast Cancer: A 20-Year Experience 118
Real-world outcomes of PARP inhibitor maintenance in advanced ovarian cancer: a focus on disease patterns and treatment modalities at recurrence 118
Avelumab Plus Intermittent Axitinib in Previously Untreated Patients with Metastatic Renal Cell Carcinoma. The Tide-A Phase 2 Study 117
Feasibility and operative outcomes of surgery in the liver area in advanced ovarian cancer 117
A clinical ultrasound algorithm to identify uterine sarcoma and smooth muscle tumors of uncertain malignant potential in patients with myometrial lesions: the MYometrial Lesion UltrasouNd And mRi study 114
Are all mismatch repair deficient endometrial cancers created equal? A large, retrospective, tertiary center experience 114
Efficacy of Lamivudine Plus Dolutegravir vs Dolutegravir-Based 3-Drug Regimens in People With HIV Who Are Virologically Suppressed 113
Robotic-assisted versus conventional laparoscopic surgery in the management of obese patients with early endometrial cancer in the sentinel lymph node era: a randomized controlled study (RObese) 113
Concurrent endometrial cancer in atypical endometrial hyperplasia and the role of sentinel lymph nodes: clinical insights from a multicenter experience 110
Predictive and prognostic value of inflammatory markers in locally advanced rectal cancer (PILLAR) - A multicentric analysis by the Italian Association of Radiotherapy and Clinical Oncology (AIRO) Gastrointestinal Study Group 109
STOMA study SToma-leak ratio in advanced ovarian cancer surgery: Results of a restrictive policy on the use of protective stoMAs 108
Flurbiprofen in the subglottic space to prevent postoperative sore throat after cardiac surgery: A randomized double-blind study 107
Implications of Genetic, Biological and Clinical Parameters in Patients With Richter Syndrome: A Monocentric Experience 104
Cytoreductive surgery for advanced epithelial ovarian cancer in the poly(ADP-ribose) polymerase inhibitors era—Is it time for a new paradigm shift? A systematic review and meta-analysis 103
Survival associated with the use of one-step nucleic acid amplification (OSNA) to detect sentinel lymph node metastasis in cervical cancer 94
Validation of the Meet-URO score in patients with metastatic renal cell carcinoma receiving first-line nivolumab and ipilimumab in the Italian Expanded Access Program 90
Less is more? Comparison between genomic profiling and immunohistochemistry-based models in endometrial cancer molecular classification: A multicenter, retrospective, propensity-matched survival analysis 89
Less is more? Comparison between genomic profiling and immunohistochemistry-based models in endometrial cancer molecular classification: A multicenter, retrospective, propensity-matched survival analysis 88
Clinical characteristics and survival outcome of early-stage, high-grade, serous tubo-ovarian carcinoma according to BRCA mutational status 84
Lymph node staging in grade 1–2 endometrioid ovarian carcinoma apparently confined to the ovary: Is it worth? 82
Ibrutinib in patients over 80 years old with CLL: a multicenter Italian cohort 81
Association of Hospital Surgical Volume With Survival in Early-Stage Cervical Cancer Treated With Radical Hysterectomy 81
Treatment Sequencing and Outcome of Chronic Lymphocytic Leukemia Patients Treated at Fondazione Policlinico Universitario Agostino Gemelli IRCCS: A Thirty-Year Single-Center Experience 81
Prediction of outcomes in chronic lymphocytic leukemia patients treated with ibrutinib: Validation of current prognostic models and development of a simplified three-factor model 80
Acalabrutinib in High-Risk Chronic Lymphocytic Leukaemia Naïve Patients: An Italian Multicenter Retrospective Observational Real-Life Experience 79
Neoadjuvant plus adjuvant combined or sequenced vemurafenib, cobimetinib and atezolizumab in patients with high-risk, resectable BRAF-mutated and wild-type melanoma: NEO-TIM, a phase II randomized non-comparative study 79
Optimizing patient selection for secondary cytoreductive surgery in recurrent endometrial cancer 79
The new surgical robot Hugo™ RAS for total hysterectomy: a pilot study 78
Protocol for an international multicenter, prospective, observational, non-competitive, study to validate and optimise prediction models of 90-day and 1-year allograft failure after liver transplantation: The global IMPROVEMENT Study 73
Prevalence of diabetes and diabetic macular edema in patients undergoing senile cataract surgery in Italy: The DIabetes and CATaract study 71
Back to the future: The impact of oestrogen receptor profile in the era of molecular endometrial cancer classification 67
Familial forms of chronic lymphocytic leukemia have a worse prognosis than sporadic forms: an Italian case-control study 52
Pathologic response and survival after neoadjuvant chemotherapy with or without pertuzumab in patients with HER2-positive breast cancer: the Neopearl nationwide collaborative study 52
Richter transformation in diffuse large B-cell lymphoma in patients with chronic lymphocytic leukemia receiving ibrutinib: risk factors and outcomes 50
Secondary analyses from a randomized clinical trial: Age as the key prognostic factor in endometrial carcinoma 49
Lifestyle and environmental factors in women carrying BRCA pathogenic variants with and without cancer 41
Microscopic assessment of lymph node status in gynecological malignancies using full-field optical coherence tomography 37
Minimally invasive simple hysterectomy in low-risk cervical cancer: a single-arm trial with stopping rules (ENGOT-cx23/MITO/LASH trial) 37
Fecal microbiota transplantation plus pembrolizumab and axitinib in metastatic renal cell carcinoma: the randomized phase 2 TACITO trial 23
Focal lymphovascular space invasion: Friend or foe? A large retrospective analysis on stage I endometrioid endometrial carcinomas 11
No lymphocytosis increase after cBTKi is a rare phenomenon except for CD49d-positive CLL mainly expressed in trisomy 12 9
Open surgery vs branched endovascular repair of the aortic arch in residual dissections after type A surgical repair 8
Long term outcomes of breast primary sarcomas and malignant phyllodes tumors: 20 years observational analysis of the BEAM∗ study group. (∗the breast European association for mesenchymal tumors) 8
Advanced-stage ALK-positive non–small-cell lung cancer (NSCLC) patients: Real-world treatment patterns and outcomes from the Italian biomarker ATLAS database 7
Minimally invasive interval debulking surgery in advanced ovarian cancer: a real-life PICture of pAtientS’ SelectiOn 7
Real-world ANASTASE study of atezolizumab+nab-paclitaxel as first-line treatment of PD-L1-positive metastatic triple-negative breast cancer 7
Developing and validating ultrasound-based machine-learning models incorporating radiomics features to predict malignancy in adnexal masses 7
Ibrutinib or non-BTK inhibitor therapy in relapsed Waldenström macroglobulinemia: a real-life multicenter Italian study 6
Laparoscopic tumor load as an independent prognostic marker in advanced ovarian cancer: a 3-year cohort study 6
Complications and Recurrence After Pelvic Exenteration for Gynecologic Malignancies: Survival Analysis From the COREPEX Study 6
A comparative analysis of tumor markers reveals EDA fibronectin as a promising target in high-grade serous ovarian cancer 5
Complications and recurrence after pelvic exenteration for gynecologic malignancies: Analysis of surgical complications from the COREPEX study 5
Prediction of germline BRCA 1/2 genes pathogenetic variants from ultrasound images of healthy ovaries: Radiogenomics as an innovative tool to prevent BRCA-related cancers (PROBE II) 4
Incidence and impact of low-volume lymph node metastasis in apparent early-stage ovarian cancer: MICR-OVARY study 4
Response to letter re: Benefit from maintenance with PARP inhibitor in newly diagnosed ovarian cancer according to BRCA1/2 mutation type and site: a multicenter real-world study 3
Benefit from maintenance with PARP inhibitor in newly diagnosed ovarian cancer according to BRCA1/2 mutation type and site: a multicenter real-world study 3
ENDOESTRO score: Where is the dark side? Evaluation of estrogen receptor expression cutoff in endometrial cancer molecular classification, an ambispective study 3
Advancing Breast Cancer Care in Patients Aged 80 and Above: A Personalized and Multidisciplinary Management to Better Outcomes 3
Predictive risk factors of recurrence in breast cancer after neoadjuvant treatment: the NEORISK study 3
Real life outcome analysis of breast cancer brain metastases treated with Trastuzumab Deruxtecan 3
Hyperthermic Intraperitoneal Chemotherapy in Platinum-Sensitive Recurrent Ovarian Cancer: A Randomized Trial on Survival Evaluation (HORSE; MITO-18) 2
Clinical Outcomes in Double-Exposed Chronic Lymphocytic Leukemia Patients in Italy 1
Totale 6.021
Salva come PNG Salva come JPEG
Categoria #
all - tutte 22.725
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.725
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/202370 0 0 0 0 0 1 2 13 4 2 16 32
2023/2024373 9 48 51 23 21 53 26 7 7 25 53 50
2024/20251.297 25 10 53 46 58 45 66 37 95 169 370 323
2025/20264.150 411 240 326 618 541 195 594 250 271 271 175 258
2026/2027131 131 0 0 0 0 0 0 0 0 0 0 0
Totale 6.021